BCM
MDT icon

Boone Capital Management’s Medtronic MDT Stock Holding History

Boone Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5M Sell
398,065
-30,724
-7% -$2.94M 10.57% 4
2025
Q4 		$41.2M Hold
428,789
– – 12.93% 1
2025
Q3 		$40.8M Hold
428,789
– – 13.39% 1
2025
Q2 		$37.4M Buy
428,789
+35,052
+9% +$2.97M 16.03% 1
2025
Q1 		$35.4M Buy
+393,737
New +$35.2M 12.04% 2

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boone Capital Management's MDT Position: Q1 2026 in Review

Boone Capital Management reduced its Medtronic (MDT) stake by 7.2% in Q1 2026, selling an estimated $2.94M and leaving 398,065 shares worth $34.5M. The position accounts for 10.57% of the portfolio, ranked #4.

Boone Capital Management first reported a position in MDT in Q1 2025 and has held it in 5 quarters since. The position peaked at $41.2M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Boone Capital Management held 398,065 shares of Medtronic worth $34.5M as of Q1 2026.
  • Boone Capital Management sold 30,724 Medtronic shares in Q1 2026, an estimated $2.94M.
  • Medtronic made up 10.57% of Boone Capital Management's portfolio in Q1 2026, its #4 holding.
  • Boone Capital Management first reported a position in Medtronic in Q1 2025 and has held it in 5 quarters since.
  • Boone Capital Management's Medtronic position peaked at $41.2M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Boone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.